跳至主要内容
临床试验/RBR-4s7gh3
RBR-4s7gh3招募中3 期

PREVER Study: Efficacy of Chlorthalidone associated with Amiloride versus Losartan in reducing blood pressure of patients with hypertension Prever 2 Study - PREVER 2: Prevention of Cardiovascular outcomes in patients with hypertension

Hospital de Clínicas de Porto Alegre0 个研究点开始时间: 2011年3月2日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
40Y 至 70Y(—)

入选标准

  • I. Individuals with 40 to 70 years, of both sexes;
  • II. Diagnosis of Hypertension in stage I, ie, systolic (SBP) between 140-159 mmHg or diastolic blood pressure (DBP) between 90-99 mmHg

排除标准

  • I. Chronic diseases that reduce life expectancy or difficulty in understanding the guidelines, which limit the possibility of participation in the study;
  • II. Refusal to participate or sign an informed consent;
  • III. Pregnancy or women most likely to become pregnant during the study;
  • IV. Known allergy to any of the study drugs;
  • V. Prior diagnosis of secondary hypertension ;

研究者

发起方
Hospital de Clínicas de Porto Alegre

相似试验

PREVER Study: Efficacy of Chlorthalidone associated... | 临床试验